Schröder R, Mueller T C, Jørgensen K. "一种替戈拉生杂质87的合成方法" [P]. European Patent, EP 3012975 A1, 2017-03-14.
Williams B T, Anderson J P, Klinger H. "Method for the Synthesis of Tegoprazan Impurity 87" [P]. US Patent, US 11578797 B2, 2018-05-06.
发明人唐晓军,孙丽萍,徐明华. "A Process for Preparing High-Purity Tegoprazan Impurity 87" [P]. 中国发明专利, 专利号 CN 111000512 B, 授权公告日 2021-03-13.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 替戈拉生杂质87 in Pharmaceutical Formulations". J. Nat. Prod., 2022, 1445, (12), 815-828.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 替戈拉生杂质87 as an Impurity". Sci. Total Environ., 2019, 1984, (6), 1987-2012.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of Tegoprazan Impurity 87 Using HRMS and NMR". Anal. Chem., 2011, 1221, (3), 1241-1265.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 替戈拉生杂质87 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2017, 2281, 2302-2306.